Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Meviton
- Development stage
- Unknown
- Lead developer
- MEPROFARM
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Meviton is an oral multivitamin supplement developed and marketed by Meprofarm. It is formulated as a film-coated tablet containing a combination of vitamin C (ascorbic acid) and essential B-complex vitamins, including vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B6 (pyridoxine), vitamin B12 (cyanocobalamin), nicotinamide, and calcium pantothenate. Meviton is indicated for the prevention and treatment of vitamin B and vitamin C deficiencies, as well as to support immune function, enhance stamina, and aid in recovery during periods of illness or physical exertion.
- Brand names
- Meviton
- Other names
- ascorbic acid + calcium pantothenate + cyanocobalamin + nicotinamide + pyridoxine + riboflavin + thiamine
Beyond the preview
Go deeper on Meviton.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Meviton.